The Mediator complex subunit Med19 extends healthy lifespan in Drosophila by preventing cellular and organismal frailty
Authors:
- Adeline PayetAPAdeline Payet
- Emmanuelle GuillouEGEmmanuelle Guillou
- Sandra Bernat-FabreSBSandra Bernat-Fabre
- Cécile Dromard-BerthézèneCDCécile Dromard-Berthézène
- Xavier ContrerasXCXavier Contreras
- Alexia RiveroARAlexia Rivero
- Denis JullienDJDenis Jullien
- Henri-Marc BourbonHBHenri-Marc Bourbon
- Jean-Louis FrendoJFJean-Louis Frendo
- Coralie SengenesCSCoralie Sengenes
- Muriel BoubeMBMuriel Boube
Preprint
Abstract
Aging involves a progressive decline in physiological functions, often marked by the onset of a “frailty point” just before survival rates decrease rapidly. Here, we investigate how the Mediator subunit Med19 modulates this transition in Drosophila . We find that upregulating Med19 extends the median lifespan by nearly 90% and postpones the onset of accelerated mortality, suggesting that Med19 helps preserve the resilience phase of aging. In contrast, Med19 downregulation sharply reduces both median and maximum lifespan, advancing the frailty threshold. We show that Med19 knockdown increases fly vulnerability to environmental insults such as oxidative and genotoxic challenges whereas Med19 upregulation helps them resist these stresses, underscoring Med19’s protective role in maintaining genomic integrity. We link these phenotypes to altered stress-response pathways at the cellular level: Med19-depleted cells show a compensatory upregulation of genes involved in iron–sulfur cluster biogenesis, glutathione metabolism, and DNA damage repair. At the cellular level, Med19 depletion triggers a “loser” phenotype in cell competition assays, activating the JNK pathway and undergoing apoptosis, highlighting a form of “cellular frailty” that parallels organismal frailty. Finally, we found that the Med19 protein level naturally decreases with age and showed that restoring Med19 expression in aged flies increases fitness and delays the onset of frailty even in older, “frail” individuals, underscoring its significance as an aging regulator. Altogether, our findings establish Med19 as a crucial mediator of lifespan and stress resilience, suggesting it acts as a rheostat that modulates the transition from healthy aging to frailty in Drosophila . GRAPHICAL Highlights: - At the organismal level, Med19 upregulation extends Drosophila lifespan by 90%, delays the onset of frailty and enhances oxidative and DNA damage stress resistance, while its depletion has the opposite effect. - Med19 depletion alters the expression of stress response genes and induces a loser-cell phenotype in cell competition assays revealing its crucial function in controlling cellular fitness. - Med19 protein levels naturally decline with age, and its restoration in aged flies improves both healthspan and lifespan.Keywords
This publication has 47 references indexed in Scilit:
- Developing a prognostic model for hepatocellular carcinoma based on MED19 and clinical stage and determining MED19 as a therapeutic targetJournal of Cancer Research and Clinical Oncology, 2024
- Cell competition: emerging signaling and unsolved questionsFEBS Letters, 2024
- Aging mechanisms—A perspective mostly from DrosophilaAdvanced Genetics, 2020
- Drosophila as a model for ageingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Involvement of Mediator complex in malignancyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- The Hallmarks of AgingCell, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Correcting developmental errors by apoptosis: lessons from Drosophila JNK signalingApoptosis, 2009
- Functional senescence in Drosophila melanogasterAgeing Research Reviews, 2005
- JNK Extends Life Span and Limits Growth by Antagonizing Cellular and Organism-Wide Responses to Insulin SignalingCell, 2005